Baltimore, MDNCT06728293Now EnrollingIRB Ready

HCC Clinical Trial in Baltimore, MD

Access cutting-edge hcc treatment through this clinical trial at a research site in Baltimore. Study-provided care at no cost to qualified participants.

Sponsored by Indiana University

Quick Self-Assessment

See if you qualify for this Baltimore location

Preparing your pre-screening questions…

Expert Care in Baltimore

Access hcc specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related hcc treatment provided free

Apply for This Baltimore Location

Check if you qualify for this hcc clinical trial in Baltimore, MD

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Baltimore

    Convenient for MD residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Baltimore site if eligible
  4. 4Begin participation

About This HCC Study in Baltimore

This study is a pilot, multi-center randomized controlled trial testing the HCC Liver-Link intervention, a culturally tailored, multi-level program designed to reduce racial disparities in hepatocellular carcinoma (HCC) care. The intervention combines: (1) patient education to improve HCC-related disease and treatment knowledge, (2) social needs and substance use screening with referral to social work and community resources, and (3) facilitated access to subspecialty cancer care through a multidisciplinary HCC tumor board. A total of 40 Black patients with Barcelona Clinic Liver Cancer (BCLC) stage 0, A, or downstaged B disease will be randomized to receive either the HCC Liver-Link intervention or usual care and followed for 6 months or until liver transplant waitlisting. Primary outcomes are time to receipt of curative therapies (liver transplantation or resection) and change in HCC-related knowledge. Findings will inform development of larger interventions to eliminate racial disparities in HCC outcomes.

Sponsor: Indiana University

Who Can Participate

Inclusion Criteria

• Within UCSF criteria: Candidates are eligible or a standardized MELD or PELD exception if, before completing locoregional therapy, they have lesions that meet one of the following criteria:
One Class 5 lesion greater than 5 cm and less than or equal to 8 cm
two or three Class 5 lesions that meeting all of the following
At least one lesion greater than 3cm
Each lesion less than or equal to 5 cm, and
A total diameter of all lesions less than or equal to 8cm
Four or five Class 5 lesions each less than 3 cm, and a total diameter of all lesions less than or equal to 8 cm.
Between 18-75 years old
Have no more than two visits with an HCC-related provider
Able to read, write, and speak English
Any 1 of the following:
Self-report as Black race (can be multiple races as long as 1 is Black)
Self-report as insured by Medicaid (+/- Medicare)
SVI (Social vulnerability index) \>= .75

Exclusion Criteria

Lacks capacity to provide informed consent, including those with stage 2 HE or higher at the time of consent.
Age over 75
Last transthoracic echocardiogram with EF\<40% (OK if no prior echo)
BMI over 50
Patients who, in the investigator's judgment, are unlikely to ever be eligible for liver transplantation or resection at the time of enrollment, with reason documented
Prior history of any solid organ transplant
Non-skin cancer malignancies other than hepatocellular carcinoma in past 2 years unless approved by PI (i.e. cervical cancer, early prostate cancer)
Patients who have undergone resection or waitlisted
Patients near completion of transplant evaluation, PI to determine utility of intervention.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Baltimore?

Yes, this clinical trial (NCT06728293) has an active research site in Baltimore, MD that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

HCC Treatment Options in Baltimore, MD

If you're searching for hcc treatment options in Baltimore, MD, this clinical trial (NCT06728293) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Baltimore research site is actively enrolling participants for this clinical trial. You'll receive care from experienced hcc specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all hcc clinical trials near you to find additional studies recruiting in your area.

More Liver Cancer Trials in Baltimore, MD

See all liver cancer clinical trials recruiting in Baltimore — not just this study.

Browse Liver Cancer Trials in Baltimore →

Browse More Trials by Condition

Liver Cancer TrialsAll Conditions →

Ready to Join in Baltimore?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Baltimore, MD